Societat Catalana de Medicina Familiar i Comunitària, Assoc. (CAMFiC)
11
0
0
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
9%
1 trials in Phase 3/4
50%
1 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Observational Study to Validate a Family Physician Echocardiography Training Programme
Role: lead
Effectiveness and Cost-effectiveness of the Initial Medication Adherence Intervention
Role: collaborator
Training to Improve Vertigo Management in Primary Care
Role: collaborator
Intervention to Improve Social and Family Support for Caregivers of Dependent Patients. (ICIAS)
Role: collaborator
Chronic Obstructive Pulmonary Disease Case Finding in Community-pharmacies by Spirometry
Role: collaborator
Effectiveness of Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease
Role: lead
Role of the Stress in the Development of the Metabolic Syndrome
Role: collaborator
Evaluation of a Combined Strategy Addressed to Practitioners and Chronic Obstructive Pulmonary Disease (COPD) Patients to Improve Clinical Control and Quality of Life
Role: collaborator
Risk Level of Suffering From Traffic Injury in Primary Health Care: LESIONAT Project
Role: collaborator
Reduction of Environmental Tobacco Smoke (ETS) Exposure at Home: the BIBE Study
Role: collaborator
Referral From Primary Health Care Centers to a Physical Activity Program. A Randomized Controlled Trial
Role: collaborator
All 11 trials loaded